Clinical Trial Update: Utidelone Injection Combined With Gemcitabine in First-line Chemotherapy for Unresectable Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating Utidelone injections combined with gemcitabine as first-line therapy for unresectable advanced pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Neoplasms

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Utidelone (utidelone)

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Pancreatic Neoplasms | Phase 2 | Status: UNKNOWN